TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,198,000 | -71.7% | 400,652 | -71.2% | 0.00% | -66.7% |
| Q2 2023 | $21,884,000 | +216.6% | 1,393,045 | +232.1% | 0.01% | +200.0% |
| Q1 2023 | $6,912,000 | +17.3% | 419,404 | +11.0% | 0.00% | 0.0% |
| Q4 2022 | $5,895,000 | +21.5% | 377,848 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $4,853,000 | -6.2% | 374,214 | +1.5% | 0.00% | 0.0% |
| Q2 2022 | $5,175,000 | -7.5% | 368,640 | -5.6% | 0.00% | +100.0% |
| Q1 2022 | $5,592,000 | +14.6% | 390,560 | +9.1% | 0.00% | 0.0% |
| Q4 2021 | $4,879,000 | -23.7% | 358,033 | -8.3% | 0.00% | -50.0% |
| Q3 2021 | $6,393,000 | -5.7% | 390,264 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $6,783,000 | -7.8% | 403,066 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $7,354,000 | +25.1% | 402,750 | +24.7% | 0.00% | 0.0% |
| Q4 2020 | $5,880,000 | -65.8% | 322,996 | -66.5% | 0.00% | -66.7% |
| Q3 2020 | $17,183,000 | +1.2% | 963,115 | +1.7% | 0.01% | 0.0% |
| Q2 2020 | $16,986,000 | +6.2% | 947,343 | -10.1% | 0.01% | -14.3% |
| Q1 2020 | $15,990,000 | -10.9% | 1,053,224 | +15.8% | 0.01% | +16.7% |
| Q4 2019 | $17,941,000 | +12.2% | 909,344 | -2.1% | 0.01% | 0.0% |
| Q3 2019 | $15,985,000 | -4.2% | 929,251 | -1.4% | 0.01% | 0.0% |
| Q2 2019 | $16,685,000 | +583.3% | 942,636 | +686.5% | 0.01% | +500.0% |
| Q1 2019 | $2,442,000 | +529.4% | 119,856 | +420.1% | 0.00% | – |
| Q4 2018 | $388,000 | – | 23,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |